Bioethical practices survey

Creating a strong dialogue with Europe’s biotech industries, in the autumn of 2007 the project surveyed companies to learn about contemporary bioethical concerns, positions and practices.
The questionnaire was distributed to 100 of the most innovative companies working in the following areas:

- Cell and Gene Therapies
- Stem Cells
- NanoBiotech
- BioBank
- Diagnostics

Presentation of the ongoing survey - Anne Cambon-Thomsen and Emmanuelle Rial-Sebbag, INSERM

Documents associés…
> Report of GBP survey - Inserm U558

This entry was posted on Lundi, juillet 20th, 2009 at 17 h 14 min and is filed under Bioethical practices survey. You can follow any responses to this entry through the RSS 2.0 feed. Responses are currently closed, but you can trackback from your own site.

Comments are closed.